Independent Portfolio Consultants’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$207K Buy
2,516
+1,396
+125% +$114K 0.09% 284
2017
Q1
$94K Buy
1,120
+940
+522% +$75.3K 0.03% 460
2016
Q4
$13K Buy
+180
New +$13.4K ﹤0.01% 680
2015
Q2
Sell
-67
Closed -$5K 961
2015
Q1
$5K Buy
+67
New +$4.77K ﹤0.01% 770

Other funds holding LLY

Independent Portfolio Consultants's LLY Position: Q2 2017 in Review

Independent Portfolio Consultants increased its Eli Lilly (LLY) stake by 125% in Q2 2017, buying an estimated $114K and bringing the position to 2,516 shares worth $207K. The position accounts for 0.09% of the portfolio, ranked #284.

Independent Portfolio Consultants first reported a position in LLY in Q1 2015 and has held it in 4 quarters since. 1,247 funds tracked by Wall St. Rank hold LLY as of Q2 2017.

  • Independent Portfolio Consultants held 2,516 shares of Eli Lilly worth $207K as of Q2 2017.
  • Independent Portfolio Consultants bought 1,396 Eli Lilly shares in Q2 2017, an estimated $114K.
  • Eli Lilly made up 0.09% of Independent Portfolio Consultants's portfolio in Q2 2017, its #284 holding.
  • Independent Portfolio Consultants first reported a position in Eli Lilly in Q1 2015 and has held it in 4 quarters since.
  • 1,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2017.

Based on Independent Portfolio Consultants's 13F filing for Q2 2017, filed 6 Jul 2017.